Press Release

Sensory Arts & Science Receives U.S. Patent 7,166,079 for MacViewer^TM

     King of Prussia, PA -- Feburary 1, 2007 -- Sensory Arts & Science today announced that the United States Patent and Trademark Office has issued patent number 7,166,079 for its MacViewer method and technology. The MacViewer is a quick and effective screening method for identifying the presence of irregularities in the macular region of the eye.

     The patent, entitled "Methods and Apparatus for Observing and Recording Irregularities of the Macula and Nearby Retinal Field", was issued on January 23, 2007. The patented method is the essence of the company's MacViewer technology, which enables the user to quickly detect abnormalities such as Age-related Macular Degeneration (ARMD) in their own eyes. The MacViewer is currently being tested in a multi-center clinical trial in the Philadelphia area in order to determine its sensitivity in detecting early stage ARMD. Further study will determine other types of pathology that may be detected with the MacViewer, such as Diabetic Retinopathy.

     Dave Davis, founder and Managing Partner of Sensory Arts & Science commented, "We are very pleased with the progress being made toward the commercial offering of the MacViewer. Obviously, gaining protection on our intellectual property is an important step in the process, and we are also making excellent progress in our phase II clinical trial efforts. The MacViewer has the potential to become the new standard of care in detecting early stage Macular Degeneration, both as a tool for physicians as well as consumers themselves. We expect to see further significant steps toward a commercially marketed product over the next 12 months."

     The MacViewer is a device or computer-based test that enables the patient to visualize irregularities in the macular region, the area of the eye that is responsible for sharpness of vision in the central visual field. ARMD affects more than 12 million people in U.S. alone and is the leading cause of functional blindness in the elder population. While there is currently no known cure for ARMD, several promising treatments are being developed and early detection has been shown to be a critical factor in halting or slowing the advance of the condition.


About Sensory Arts & Science

     Sensory Arts & Science is a research and development company focused on creating novel diagnostic tools for conditions and diseases that affect the human sensory systems. The Company, founded in 2001 has already successfully commercialized technologies in the area of human hearing and olfactory function, and has a pipeline of new and important technologies that will be developed and commercialized over the next several years. For more information, please contact Dave Davis, at (610) 768-9300.